EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Clinico-epidemiological, therapeutic and prognostic aspects of cavum cancer in Mostaganem

Habib ZIDANE, Nesrine ZAHI, Mohamed Hadjar KHERFANE

Batna Journal of Medical Sciences (BJMS) · 2026

DOI: 10.48087/bjms.2026.130103 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Nasopharyngeal carcinoma is common in Algeria. Its worldwide incidence is geographically dependent, diagnosis is often delayed, and prognosis remains guarded despite high radiosensitivity. Methods: This retrospective study was conducted from January 2021 to August 2024 in the medical oncology department of Mostaganem University Hospital and included 49 cases of nasopharyngeal carcinoma. Results: The mean age was 50.2 years, with 83.7% males (n=41) and 73.5% (n=36) non-smokers. The median time to diagnosis was 4 months (range: 1-20 months). Cervical lymphadenopathy was palpated in all patients, while the oto-rhino-neurological triad was present in 10.2% of cases (n=5). Undifferentiated nasopharyngeal carcinoma was diagnosed in 93.9% of cases (n=46). T4 tumors were found in 24.5% (n=12) and M1 disease in 8.2% (n=4). Chemotherapy was administered to 47 patients, with neoadjuvant chemotherapy in 89.4% (n=42). The PTX protocol (cisplatin, docetaxel, capecitabine) was used in the majority of cases (n=40), with a mean of 3.4 cycles (range: 1-9 cycles). The complete response rate to neoadjuvant chemotherapy was 16.7% (n=7). Radiotherapy was performed in 42 patients, with a mean delivered dose of 62.46 Gy (range: 30-70 Gy). Five patients died during the study period, yielding a three-year overall survival rate of 89.6%. Conclusion: Nasopharyngeal carcinoma is a relatively common tumor in Algeria, often diagnosed at an advanced stage. It is chemosensitive and radiosensitive, with radiotherapy as the primary treatment. Survival analysis showed a trend toward better outcomes in male patients under 60 years of age with minimal lymph node involvement (N1); however, these associations did not reach statistical significance. Further studies are needed to establish a comprehensive profile of nasopharyngeal carcinoma in Algeria.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →